白质过强度缓解糖尿病与非AD脑缩之间的关联
Jiangbo Cui1,2, Zhaojun Liu3, Wei Ying Tan4
1Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Diabetes care
|October 27, 2025
概括
糖尿病和白质高强度 (WMHs) 协同加速大脑缩,独立于阿尔茨海默病. 这种相互作用,而不仅仅是糖尿病,通过脑血管变化驱动认知障碍.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 内分泌学 在内分泌学.
背景情况:
- 已知白质超强度 (WMHs) 可以调节糖尿病和认知功能之间的关系.
- 这种相互作用背后的精确机制,特别是关于大脑结构的精确机制,仍然在很大程度上未被探索.
研究的目的:
- 研究糖尿病和WMHs对大脑缩的相互作用作用.
- 为了识别由这种相互作用引起的特定缩模式.
- 为了确定大脑缩是否介导糖尿病对认知表现的影响.
主要方法:
- 分析了两个独立的队列 (协调和ADNI),包括没有痴呆症的个人.
- 纵向脑MRI和认知评估.
- 量化WMHs,全球和AD特异性脑缩 (施瓦兹特征,麦克埃维特征,海马体积) 和血pTau181水平.
主要成果:
- 糖尿病与大脑缩没有直接关联.
- 观察到糖尿病和WMH之间的显著相互作用,加速大脑缩,特别是在皮质灰质和额叶.
- 皮质灰质缩调解了糖尿病对高WMH负担的个体认知的影响.
结论:
- 糖尿病和WMHs协同相互作用,促进大脑缩,独立于阿尔茨海默病的病理学.
- 这些发现表明,与糖尿病相关的认知障碍主要是由脑血管疾病机制驱动的,而不是阿尔茨海默病的病理.
更多相关视频
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
40.8K
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.4K
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
432
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
432
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
